Methyl imidazo[1,2-b]pyridazine-6-carboxylate

Catalog No. :
ACQBGO640
CAS No. :
1234616-21-7
Molecular Formula :
C8H7N3O2
Molecular Weight :
177.16

IUPAC Name:methyl imidazo[1,2-b]pyridazine-6-carboxylate

Methyl imidazo[1,2-b]pyridazine-6-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$92.00Login to see priceIn stockInquiry
5g97%$274.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl imidazo[1,2-b]pyridazine-6-carboxylate
IUPAC Namemethyl imidazo[1,2-b]pyridazine-6-carboxylate
MDL No.MFCD16039336
Molecular FormulaC8H7N3O2
Molecular Weight177.16
SMILESO=C(C1=NN2C(C=C1)=NC=C2)OC
InChI KeyMMNCMZRUTZBGOH-UHFFFAOYSA-N
SynonymMETHYL IMIDAZO[1,2-B]PYRIDAZINE-6-CARBOXYLATE | 1234616-21-7 | MFCD16039336 | Imidazo[1,2-b]pyridazine-6-carboxylic acid, methyl ester | IMIDAZO[1,2-B]PYRIDAZINE-6-CARBOXYLIC ACID METHYL ESTER | SCHEMBL297434 | MMNCMZRUTZBGOH-UHFFFAOYSA-N | DTXSID501236451 | AMY34209 | AKO
CAS No.1234616-21-7
PubChem CID59580147

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACQBGO640 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. ACTEVU478 route compound structure diagram
    ACTEVU4786775-78-6 In Stock
  4. Plus
  5. ACHUHQ605 route compound structure diagram
    --
  6. Then
  7. ACQBGO640 route product structure diagram
    ACQBGO6401234616-21-7 In Stock
Inquiry

2. ACQBGO640 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVLH469 route compound structure diagram
    ACQVLH469769109-13-9 In Stock
  2. Then
  3. ACQBGO640 route product structure diagram
    ACQBGO6401234616-21-7 In Stock
Inquiry

Comments (0)